Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...
Eli Lilly has dominated headlines in recent months, recently taking the crown as the most valuable company in the biopharma ...
Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platformSidewinder's pipeline of precision bispecific ADCs combined with Lonza's clinically validated ...
Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer base Advance SeaStar Medical's first-in-class SCD therapy for the adult AKI indication - a potent ...
Camping Kiddos on MSN
The ultimate 1 day in Glacier National Park itinerary
If you only have one day in Glacier National Park, make the most of it with this helpful itinerary! Known as the “Crown of ...
Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback